27 October 2026 10:00 - 10:30
The enduring role of product trials in the AI era
73% of B2B deals now involve three or more departments, with 13 people inside your buyer's org and nine more weighing in before sign-up. Worse, half form opinions with AI before the trial even starts. Therefore, your trial no longer convinces one champion but needs to convince a committee of people or AI agents you may never see. What’s worse is that most are primed with info, and half are already decided. Join Clive as he makes the case for why product trials remain the most persuasive asset in your GTM stack, and the pitfalls to avoid with an AI-empowered buying committee.
Key takeaways:
- Why more stakeholders doing more AI research earlier raises the bar for what your trial has to prove
- How to design for silent evaluators who show up with an AI-formed opinion already in hand
- What to build into onboarding so non-technical stakeholders "get it" without a demo or a human
- A framework for measuring trial performance beyond signups: influence, spread, and conversion across a committee shaped by AI before it reaches you